Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Warrants and options expiring

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Jun 07, 2024 7:30pm

136 Views

Post# 36078718

RE:RE:RE:RE:RE:RE:Warrants and options expiring

You guys are jokers, $1 really? I don't think there a single real shareholder that would vote for that.

menoalittle wrote: As long as it's a stock exchange and not a cash offer, I have no doubt that there would be many millions of other shares that would vote likewise. At this point, I just don't think there's all that many that have given this any thought whatsoever.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading